AstraZeneca asks FDA to authorize Covid antibo... - CLL Support

CLL Support

23,335 members40,035 posts

AstraZeneca asks FDA to authorize Covid antibody treatment -it would be the first long-acting drug for people with compromised immune....

DanBro1 profile image
7 Replies

AstraZeneca, the drugmaker that developed one of the first Covid-19 vaccines, has asked the Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease.

The Anglo-Swedish company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency authorization for COVID-19 prevention. If authorized, the drug would likely be limited to people with compromised immune systems who don't get sufficient protection from vaccination.

"First and foremost we want to protect those vulnerable populations that haven’t been adequately protected by the vaccine," said Menelas Pangaloa, AstraZeneca's head of research and development.

Written by
DanBro1 profile image
DanBro1
To view profiles and participate in discussions please or .
Read more about...
7 Replies
Pin57 profile image
Pin57

Great news for folks (like us) with compromised immune systems! Thanks for posting this Danbro.

annmcgowan profile image
annmcgowan

Great news thanks for sharing. Hopefully the U.K. will follow suit?Ann

1962jns profile image
1962jns

Would this be a pill or injection?

DanBro1 profile image
DanBro1 in reply to1962jns

"The FDA has stressed that antibody drugs are not a substitute for vaccination, which is the most effective, long-lasting form of virus protection.

Antibody drugs also are expensive to produce and require an IV or injection and healthcare workers to administer.

Late-stage human trials showed that AstraZeneca’s antibody drug reduced the risk of developing symptomatic COVID-19 by 77%."

Phil4-13 profile image
Phil4-13

Great news!🙂Sandra

Jonquiljo profile image
Jonquiljo

I think it would be a great idea! It would be a very helpful tool in this pandemic. Unfortunately, the American government is still asleep at the wheel. If it gets approved, it will likely take a long time to get approval. It will be tied up in government procurement and bureaucrats deciding as to how best distribute these things.

I’m not trying to be “debbie-downer” but our country seems to be turning a blind eye to Covid when compared to earlier times. We cant even get home Covid tests on the market and plentiful.

So as “medical authorities” continue to argue the validity of booster shots for about the 6th week in a row, AZD7442 will get stuck in a big puddle of mud?

I wouldn’t be negative like this if it weren’t true. Covid needs to be #1 on a national agenda! We have the tools to stop Covid in its tracks - but we can’t seem to get the momentum to work on it.

Loves2walk profile image
Loves2walk

Hopefully Canada will be included! We seem to be slow but sure?

Not what you're looking for?

You may also like...

Astrazenecas new antibody drug for immune compromised people

https://www.msn.com/en-us/health/medical/astrazeneca-submits-preventive-covid-19-treatment-to-fda/ar
craterlake profile image

Important SARS-CoV-2 and Covid-19 information for Chronic Lymphocytic Leukaemia/CLL patients

This post, prepared in collaboration with        @[52122] , draws together some earlier posts...
CLLerinOz profile image
Administrator

Ronapreve approved for CEV patients in UK

From the GOV.UK website Thousands of vulnerable NHS patients in hospital due to COVID-19 are set to...
Jm954 profile image
Administrator

The UK RECOVERY Trial closes Recruitment to the Convalescent Plasma treatment arm for patients hospitalised with COVID-19

The RECOVERY trial independent Data Monitoring Committee (DMC) held a routine meeting on Thursday...
Jm954 profile image
Administrator

UK only - COVID Cancer Antibody Survey

The NHS has launched a national COVID Cancer Antibody Survey to assess antibody responses to the...
Jm954 profile image
Administrator